Volume 17, issue 4, October 2020
Therapeutic Advances in Movement Disorders
56 articles in this issue
-
-
-
-
Therapy of Parkinson’s Disease Subtypes
Authors (first, second and last of 4)
-
-
-
-
Current Perspectives on Aerobic Exercise in People with Parkinson’s Disease
Authors (first, second and last of 4)
-
-
-
-
-
Approach to Cognitive Impairment in Parkinson’s Disease
Authors (first, second and last of 5)
-
-
-
-
Four-Repeat Tauopathies: Current Management and Future Treatments
Authors (first, second and last of 5)
-
-
Managing Essential Tremor
Authors
-
-
-
-
-
Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments
Authors
-
-
-
-
Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential
Authors (first, second and last of 9)
-
Treating Post-traumatic Stress Disorder with Neuromodulation Therapies: Transcranial Magnetic Stimulation, Transcranial Direct Current Stimulation, and Deep Brain Stimulation
Authors (first, second and last of 10)
-
-
The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis
Authors (first, second and last of 6)
-
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson’s Disease
Authors (first, second and last of 11)
-
FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson’s Disease
Authors (first, second and last of 11)
-
Allopregnanolone Promotes Neuronal and Oligodendrocyte Differentiation In Vitro and In Vivo: Therapeutic Implication for Alzheimer’s Disease
Authors (first, second and last of 4)
-
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer’s Disease
Authors (first, second and last of 18)
-
Novel Compounds Identified by Structure-Based Prion Disease Drug Discovery Using In Silico Screening Delay the Progression of an Illness in Prion-Infected Mice
Authors (first, second and last of 7)
-
Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice
Authors (first, second and last of 10)
-
Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice
Authors (first, second and last of 12)
-
Methionine-Mediated Protein Phosphatase 2A Catalytic Subunit (PP2Ac) Methylation Ameliorates the Tauopathy Induced by Manganese in Cell and Animal Models
Authors (first, second and last of 14)
-
The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
Authors (first, second and last of 7)
-
Intranasal Dexamethasone Reduces Mortality and Brain Damage in a Mouse Experimental Ischemic Stroke Model
Authors (first, second and last of 12)
-
Proactive Motor Functional Recovery Following Immersive Virtual Reality–Based Limb Mirroring Therapy in Patients with Subacute Stroke
Authors (first, second and last of 15)
-
Reperfusion plus Selective Intra-arterial Cooling (SI-AC) Improve Recovery in a Nonhuman Primate Model of Stroke
Authors (first, second and last of 15)
-
Recombinant CCL17 Enhances Hematoma Resolution and Activation of CCR4/ERK/Nrf2/CD163 Signaling Pathway After Intracerebral Hemorrhage in Mice
Authors (first, second and last of 8)
-
Pituitary Adenylate Cyclase-Activating Polypeptide Attenuates Brain Edema by Protecting Blood–Brain Barrier and Glymphatic System After Subarachnoid Hemorrhage in Rats
Authors (first, second and last of 15)
-
Cortical Mechanisms of Single-Pulse Transcranial Magnetic Stimulation in Migraine
Authors (first, second and last of 9)
-
Inhibition of the BMP Signaling Pathway Ameliorated Established Clinical Symptoms of Experimental Autoimmune Encephalomyelitis
Authors (first, second and last of 9)
-
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy
Authors (first, second and last of 9)
-
Brachyury Is Associated with Glioma Differentiation and Response to Temozolomide
Authors (first, second and last of 4)
-
Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics
Authors (first, second and last of 9)
